Top Markets
Coin of the day
BioDelivery Sciences International, Inc. BioDelivery Sciences International, Inc.

BioDelivery Sciences International, Inc.

BDSI
Rankning i aktier #16145
BioDelivery Sciences International, Inc. (BDSI) is a specialized pharmaceutical... BioDelivery Sciences International, Inc. (BDSI) is a specialized pharmaceutical firm dedicated to the advancement and commercialization of therapeutic products designed for long-term health conditions, serving markets both within the United States and internationally. The company's product offerings leverage its proprietary BioErodible MucoAdhesive drug delivery system—a slender, dissolving polymer film intended for application to the inner cheek—in addition to other drug administration methodologies. Its portfolio includes several key products: BELBUCA, a buprenorphine buccal film, is utilized for the ongoing management of persistent pain. Symproic functions as a peripherally acting mu-opioid receptor antagonist, specifically addressing opioid-induced constipation in adult patients suffering from chronic non-cancer pain. This also covers individuals whose chronic pain is a result of prior cancer or its treatment, provided they do not require frequent increases in opioid dosage. ELYXYB, an oral solution containing celecoxib, provides treatment for adult migraines, irrespective of the presence of an aura. ONSOLIS, a soluble fentanyl film administered buccally, is intended for the management of sudden, severe "breakthrough" pain experienced by cancer patients. Founded in 1997, BioDelivery Sciences International, Inc. is headquartered in Raleigh, North Carolina. As of March 18, 2022, the company operates as a subsidiary of Collegium Pharmaceutical, Inc.
Aktiekurs
$5.59
Senast synkroniserad: 2022-03-31
Marknadsvärde
$310.83M
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
US
Handel BioDelivery Sciences International, Inc. (BDSI)

Kategori

Antal utestående aktier för BioDelivery Sciences International, Inc. (BDSI)
Antal utestående aktier per September 2026: 0
Enligt de senaste finansiella rapporterna och aktiekursen för BioDelivery Sciences International, Inc. är det aktuella antalet utestående aktier 0. I slutet av September 2026 hade företaget 0 utestående aktier. Antalet utestående aktier påverkas vanligtvis av aktiesplit och återköp av aktier.
Historik över utestående aktier för BioDelivery Sciences International, Inc. (BDSI) från 2026 till 2026
Utestående aktier vid slutet av varje år
År Utestående aktier Ändra
Inte tillräckligt med data för de angivna datumen.
Utestående aktier för liknande företag eller konkurrenter